Lantheus Holdings, Inc. (BIT:1LNTH)
Italy
· Delayed Price · Currency is EUR 72.06
+0.80 (1.12%)
At close: May 12, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Other Radiopharmaceutical Oncology | - |
Log In |
Log In |
Log In |
Log In |
| Other Radiopharmaceutical Oncology Growth | - |
Log In |
Log In |
Log In |
Log In |
| Total Radiopharmaceutical Oncology | 1.06B |
Log In |
Log In |
Log In |
Log In |
| Total Radiopharmaceutical Oncology Growth | 15.16% |
Log In |
Log In |
Log In |
Log In |
| DEFINITY | 320.44M |
Log In |
Log In |
Log In |
Log In |
| DEFINITY Growth | 11.45% |
Log In |
Log In |
Log In |
Log In |
| TechneLite | 93.48M |
Log In |
Log In |
Log In |
Log In |
| TechneLite Growth | 6.11% |
Log In |
Log In |
Log In |
Log In |
| Other Precision Diagnostics | 23.74M |
Log In |
Log In |
Log In |
Log In |
| Other Precision Diagnostics Growth | 2.75% |
Log In |
Log In |
Log In |
Log In |
| Total Precision Diagnostics | 437.66M |
Log In |
Log In |
Log In |
Log In |
| Total Precision Diagnostics Growth | 9.77% |
Log In |
Log In |
Log In |
Log In |
| Strategic Partnerships and Other | 42.42M |
Log In |
Log In |
Log In |
Log In |
| Strategic Partnerships and Other Growth | -14.15% |
Log In |
Log In |
Log In |
Log In |
| PYLARIFY | 1.06B |
Log In |
Log In |
Log In |
Log In |
| PYLARIFY Growth | 15.51% |
Log In |
Log In |
Log In |
Log In |
| Product | 1.52B |
Log In |
Log In |
Log In |
Log In |
| Product Growth | 13.60% |
Log In |
Log In |
Log In |
Log In |
| License and Royalty | 14.31M |
Log In |
Log In |
Log In |
Log In |
| License and Royalty Growth | -43.86% |
Log In |
Log In |
Log In |
Log In |